COLD SPRING HARBOR LABORATORY

EIN: 112013303 501(c)(3) Science & Technology

COLD SPRING HARBOR, NY

Total Revenue
$257,960,426
Total Expenses
$190,674,658
Total Assets
$1,242,678,094
Net Assets
$1,099,920,486
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1924
Legal Domicile
NY
Principal Officer
BRUCE STILLMAN
Phone
5163678448
Tax Period
2023-01-01 to 2023-12-31

COLD SPRING HARBOR LABORATORY, founded in 1924, is a major nonprofit in the Science & Technology sector that reported $258.0M in total revenue in fiscal year 2023. Revenue surged 24% from the prior year, signaling strong growth momentum. The organization ran a surplus of $67.3M, a strong 26% operating margin.

Mission

THE ORGANIZATION CONDUCTS RESEARCH IN THE BIOLOGICAL SCIENCES WITH A PARTICULAR EMPHASIS ON BASIC RESEARCH IN MOLECULAR BIOLOGY AND GENETICS.

Program Service Accomplishments

Program 1
Expenses: $121,165,566 Revenue: $787,382

RESEARCH: COLD SPRING HARBOR LABORATORY (CSHL), FOUNDED IN 1890, IS A WORLD-RENOWNED, PRIVATE RESEARCH AND EDUCATION INSTITUTION WITH RESEARCH PROGRAMS IN CANCER, NEUROSCIENCE, PLANT BIOLOGY...

Read more

RESEARCH: COLD SPRING HARBOR LABORATORY (CSHL), FOUNDED IN 1890, IS A WORLD-RENOWNED, PRIVATE RESEARCH AND EDUCATION INSTITUTION WITH RESEARCH PROGRAMS IN CANCER, NEUROSCIENCE, PLANT BIOLOGY, QUANTITATIVE BIOLOGY, AND BIOINFORMATICS & GENOMICS. THE RESEARCH ENVIRONMENT IS HIGHLY COLLABORATIVE, ALLOWING CSHL SCIENTISTS TO WORK TOGETHER ACROSS DISCIPLINES TO SOLVE BIOLOGY'S MOST CHALLENGING PROBLEMS. THE ULTIMATE GOAL IS TO APPLY THIS RESEARCH ON BASIC BIOLOGICAL MECHANISMS TO IMPROVE THE DIAGNOSIS AND TREATMENT OF CANCER, NEUROLOGICAL DISORDERS AND OTHER DISEASES. (SEE SCHEDULE O)(CONTINUED FROM PART III)RESEARCH AT THE LABORATORY IS ENRICHED BY COLLABORATIONS WITH SCIENTISTS AT OTHER UNIVERSITIES, HOSPITALS AND IN THE BIOTECH AND PHARMACEUTICAL SECTORS. THESE PARTNERINGS HAVE INCLUDED NYU, MEMORIAL SLOAN-KETTERING, WEILL CORNELL AND HARVARD. THE INNOVATIVE SPIRIT, VISION AND TALENT OF THE LABORATORY'S OVER 600 SCIENTISTS CONTINUE TO PLACE CSHL AMONG THE TOP 1% OF LIFE SCIENCE INSTITUTIONS MOST CITED IN PUBLISHED RESEARCH. THE LABORATORY HAS BEEN A NATIONAL CANCER INSTITUTE-DESIGNATED CANCER CENTER WITH AN NCI "OUTSTANDING" RATING. IT HAS BEEN HOME TO EIGHT NOBEL LAUREATES, INCLUDING BARBARA MCCLINTOCK, DISCOVERER OF THE "JUMPING GENES". THE LABORATORY OFFERS AN ADVANCED DRUG TESTING FACILITY DELIVERING WELL-VALIDATED DRUG CANDIDATES TO BOTH THE BIOTECH AND PHARMACEUTICAL INDUSTRY. SINCE 2015, CSHL HAS HAD AN AFFILIATION WITH NORTHWELL HEALTH, THE AFFILIATION HAS LAUNCHED NEW EDUCATION INITIATIVES, EXPANDED ACCESS TO CLINICAL TRIALS, AND PROVIDED FUNDING FOR NEW INVESTIGATIONS THAT WILL HAVE A RAPID IMPACT IN THE CLINIC. TOGETHER, CSHL AND NORTHWELL HEALTH ARE COMMITTED TO BRINGING OUR DISCOVERIES OUT OF THE LAB AND TO THE PATIENTS. AS A TEAM, WE ARE POISED TO IDENTIFY NEW CANCER DIAGNOSTICS AND THERAPEUTICS THAT WILL MORE EFFECTIVELY AND RAPIDLY TREAT CANCER THAN EVER BEFORE.

Program 2
Expenses: $19,659,760 Revenue: $13,123,782

EDUCATIONAL MEETINGS & COURSES PROGRAM: CSHL'S REPUTATION AS ONE OF THE PREMIER HUBS OF ACTIVITY IN BIOLOGY AND GENETICS IS LINKED TO ITS MEETINGS AND COURSES PROGRAM. WITH ROOTS IN THE LEGENDARY...

Read more

EDUCATIONAL MEETINGS & COURSES PROGRAM: CSHL'S REPUTATION AS ONE OF THE PREMIER HUBS OF ACTIVITY IN BIOLOGY AND GENETICS IS LINKED TO ITS MEETINGS AND COURSES PROGRAM. WITH ROOTS IN THE LEGENDARY ANNUAL SYMPOSIA IN QUANTITATIVE BIOLOGY SERIES, WHICH BEGAN IN 1933, THE PROGRAM ORGANIZES MORE THAN 60 MEETINGS AND COURSES ANNUALLY, COVERING A WIDE RANGE OF TOPICS IN THE BIOLOGICAL SCIENCES. IN 2023, THE PROGRAM CONTINUED TO SUCCESSFULLY HOLD VIRTUAL MEETINGS AND COURSES ATTRACTING CLOSE TO 13,000 PARTICIPANTS. (SEE SCHEDULE O)(CONTINUED FROM PART III)PARTICIPANTS RANGE FROM THE MOST ACCOMPLISHED SENIOR INVESTIGATORS TO GRADUATE STUDENTS AND POSTDOCS. PROGRAMS ARE PUT TOGETHER ON THE BASIS OF OPENLY SUBMITTED ABSTRACTS AND INCLUDE DISCUSSIONS OF UNPUBLISHED WORK. CSH ASIA, A CSHL-STYLED MEETING PROGRAM, BEGAN IN 2009, AND CONTINUES TO OPERATE IN SUZHOU, CHINA.

Program 3
Expenses: $10,438,087 Revenue: $9,442,510

PUBLICATIONS: WITH ORIGINS IN THE 1930'S, CSHL PRESS ENHANCES THE LABORATORY'S EDUCATIONAL MISSION BY PUBLISHING ORIGINAL WORK THAT ASSISTS IN THE ADVANCE AND SPREAD OF SCIENTIFIC KNOWLEDGE. SALE OF...

Read more

PUBLICATIONS: WITH ORIGINS IN THE 1930'S, CSHL PRESS ENHANCES THE LABORATORY'S EDUCATIONAL MISSION BY PUBLISHING ORIGINAL WORK THAT ASSISTS IN THE ADVANCE AND SPREAD OF SCIENTIFIC KNOWLEDGE. SALE OF ITS PUBLICATIONS ENHANCES THE LABORATORY'S INTERNATIONAL REPUTATION FOR EXCELLENCE. THE PRESS PUBLISHES RESEARCH AND REVIEW JOURNALS, BOOKS, MANUALS, PRIMERS AND OTHER INFORMATION SOURCES, IN ELECTRONIC AND PRINT FORM. IN 2023, THE PRESS PUBLISHED 278 PRINT BOOKS, INCLUDING 7 NEW TITLES. THE PRESS ALSO PRODUCES 3 PRINT/ONLINE JOURNALS, 4 ONLINE ONLY JOURNALS AND 2 NO-CHARGE JOURNALS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $189,476,585
Program Service Revenue $26,115,795
Investment Income $22,188,012
Other Revenue $20,180,034
TOTAL REVENUE $257,960,426

Expense Breakdown

Grants Paid $6,140,824
Salaries & Benefits $99,522,885
Fundraising Expenses $2,164,800
Program Expenses $157,316,413
Other Expenses $85,010,949
TOTAL EXPENSES $190,674,658

Year-over-Year Comparison

2023 2022 Change
Revenue $257,960,426 $207,360,887 +0.2%
Expenses $190,674,658 $183,981,090 +0.0%
Net Income $67,285,768 $23,379,797 +1.9%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
32
Independent Members
31
Employees
1209
Volunteers
58

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
6
$4,257,277
Total Directors
34
$3,195,129
Key Employees
3
$1,786,106
Highest Compensated
5
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
BRUCE RATNER TRUSTEE 1.00
Director
$0 $0 $0
BRUCE STILLMAN PHD CEO AND TRUSTEE 39.00
Officer Director
$3,033,951 $161,178 $3,195,129
CHARLES I COGUT VICE CHAIRMAN 1.00
Director
$0 $0 $0
CHRISTINE ANDERSON TRUSTEE 1.00
Director
$0 $0 $0
DAVID BOIES TRUSTEE 1.00
Director
$0 $0 $0
DIANA L TAYLOR TRUSTEE 1.00
Director
$0 $0 $0
DOUGLAS SCHLOSS TRUSTEE 1.00
Director
$0 $0 $0
ELAINE FUCHS PHD TRUSTEE 1.00
Director
$0 $0 $0
ELIZABETH COGAN FASCITELLI TRUSTEE 1.00
Director
$0 $0 $0
ELIZABETH MCCAUL PHD TREASURER 1.00
Director
$0 $0 $0
ELLEN V FUTTER TRUSTEE (AS OF 6/2023) 1.00
Director
$0 $0 $0
GEOFFREY ROBERTSON TRUSTEE 1.00
Director
$0 $0 $0
GEORGE D YANCOPOULOS MD PHD TRUSTEE (THRU 11/2023) 1.00
Director
$0 $0 $0
HOWARD L MORGAN PHD TRUSTEE 1.00
Director
$0 $0 $0
JAMES M STONE PHD TRUSTEE 1.00
Director
$0 $0 $0
JAMIE C NICHOLLS TRUSTEE 1.00
Director
$0 $0 $0
JEAN MOUTOUSSAMY-ASHE TRUSTEE 1.00
Director
$0 $0 $0
JEFFREY E KELTER TRUSTEE 1.00
Director
$0 $0 $0
JOANNE BERGER-SWEENEY PHD TRUSTEE (THRU 1/2023) 1.00
Director
$0 $0 $0
KAREL SVOBODA PHD TRUSTEE 1.00
Director
$0 $0 $0
LALIT R BAHL PHD TRUSTEE 1.00
Director
$0 $0 $0
LAURA SLATKIN TRUSTEE 1.00
Director
$0 $0 $0
LAURIE J LANDEAU VMD TRUSTEE 1.00
Director
$0 $0 $0
LYON POLK TRUSTEE 1.00
Director
$0 $0 $0
MARILYN H SIMONS PHD CHAIRMAN 1.00
Officer Director
$0 $0 $0
MARK CLASTER TRUSTEE 1.00
Director
$0 $0 $0
MARK HAMER TRUSTEE (AS OF 1/2023) 1.00
Director
$0 $0 $0
MICHAEL R BOTCHAN PHD TRUSTEE 1.00
Director
$0 $0 $0
PAUL J TAUBMAN VICE CHAIRMAN 1.00
Officer Director
$0 $0 $0
ROBERT D LINDSAY VICE-CHAIRMAN 1.00
Director
$0 $0 $0
ROBERT W LOURIE PHD SECRETARY 1.00
Director
$0 $0 $0
STUART WEISBROD PHD TRUSTEE 1.00
Director
$0 $0 $0
THOMAS LISTER TRUSTEE 1.00
Director
$0 $0 $0
TRACY JOHNSON PHD TRUSTEE 1.00
Director
$0 $0 $0
JOHN TUKE CHIEF OPERATING OFFICER 39.00
Officer
$568,098 $115,221 $683,319
NICHOLAS MILOWSKI CFO (AS OF 11/2023) 39.00
Officer
$76,560 $11,786 $88,346
SCOTT QUEHL CFO (THRU 4/2023) 39.00
Officer
$283,831 $6,652 $290,483
DAVID SPECTOR DIRECTOR OF RESEARCH 40.00
Key Emp
$907,784 $71,565 $979,349
STEPHEN MONEZ VP CHIEF FACILITIES OFFICER 40.00
Key Emp
$314,929 $69,185 $384,114
WALTER GOLDSCHMIDTS VP, SPONSORED PROGRAMS 39.00
Key Emp
$349,638 $73,005 $422,643
ANTHONY ZADOR SCIENTIST 40.00
Highest
$397,761 $73,781 $471,542
CHARLES V PRIZZI SENIOR VP ADVANCEMENT 40.00
Highest
$418,828 $73,890 $492,718
DAVID TUVESON SCIENTIST 40.00
Highest
$436,086 $57,907 $493,993
MICHAEL WIGLER SCIENTIST 40.00
Highest
$427,233 $71,296 $498,529
NICHOLAS TONKS SCIENTIST 40.00
Highest
$392,294 $73,081 $465,375
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $257,960,426 $190,674,658 $1,242,678,094 $67,285,768
2022 $207,360,887 $183,981,090 $1,112,826,649 $23,379,797
2021 $202,293,920 $170,447,277 $1,175,223,746 $31,846,643
2021 $202,293,920 $170,447,277 $1,175,223,746 $31,846,643
2020 $184,434,708 $165,964,650 $1,109,130,778 $18,470,058
2019 $307,604,088 $183,952,370 $1,055,985,344 $123,651,718
2018 $212,525,469 $174,527,175 $889,607,306 $37,998,294
Explore More Nonprofits
Top 100 Nonprofits in New York Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare COLD SPRING HARBOR LABORATORY with other nonprofits in New York and across the country.